Protecting pregnant women from malaria in areas of high HIV infection prevalence

Journal of Infectious Diseases

Volumn 194, Issue 3, 2006, Pages 273-275

  Meshnick, Steven R ^a   Mwapasa, Victor ^b   Rogerson, Stephen J ^c  

^a IL   (United States)

^b UNIVERSITY OF MALAWI   (Malawi)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; FANSIDAR; HEMOZOIN; INSECTICIDE; SULFADOXINE;

AFRICA; ANEMIA; BED NET; BIRTH DEFECT; CHEMOPROPHYLAXIS; DISEASE EXACERBATION; DRUG HALF LIFE; DRUG INTERMITTENT THERAPY; EDITORIAL; EPIDEMIC; FEMALE; FOLIC ACID DEFICIENCY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; LOW BIRTH WEIGHT; MALARIA; MALAWI; MATERNAL ANEMIA; OPPORTUNISTIC INFECTION; PARASITEMIA; PLASMODIUM FALCIPARUM; PREGNANT WOMAN; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RISK REDUCTION; SHORT COURSE THERAPY; TABLET; VIRUS LOAD; WORLD HEALTH ORGANIZATION; ZAMBIA;

AFRICA SOUTH OF THE SAHARA; ANTIMALARIALS; CHEMOPREVENTION; DISEASE OUTBREAKS; DRUG COMBINATIONS; FEMALE; HIV INFECTIONS; HUMANS; MALARIA, FALCIPARUM; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PREVALENCE; PYRIMETHAMINE; SULFADOXINE; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 33746377643     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/505087     Document Type: Editorial

References (33)

1. Guyatt HL, Snow RW. Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa. Clin Microbiol Rev 2004; 17: 760-9.
2. Brabin BJ. An analysis of malaria in pregnancy in Africa. Bull World Health Organ 1983; 61: 1005-16.
3. McGregor IA. Epidemiology, malaria and pregnancy. Am J Trop Med Hyg 1984; 33: 517-25.
4. Asamoah-Odei E, Asiimwe-Okiror G, Garcia Calleja JM, Boerma JT. Recent trends in HIV prevalence among pregnant women in sub-Saharan Africa. AIDScience 2003; 3:39.
5. Mwapasa V, Rogerson SJ, Molyneux ME, et al. The effect of Plasmodium falciparum malaria on peripheral and placental HIV-1 RNA concentrations in pregnant Malawian women. AIDS 2004; 18:1051-9.
6. Mount AM, Mwapasa V, Elliott SR, et al. Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection. Lancet 2004; 363:1860-7.
7. Verhoeff FH, Brabin BJ, Hart CA, Chimsuku L, Kazembe P, Broadhead RL. Increased prevalence of malaria in HIV-infected pregnant women and its implications for malaria control. Trop Med Int Health 1999; 4:5-12.
8. Steketee RW, Wirima JJ, Bloland PB, et al. Impairment of a pregnant woman's acquired ability to limit Plasmodium falciparum by infection with human immunodeficiency virus type-1. Am J Trop Med Hyg 1996; 55:42-9.
9. ter Kuile FO, Parise ME, Verhoeff FH, et al. The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-Saharan Africa. Am J Trop Med Hyg 2004; 71:41-54.
10. World Health Organization (WHO). A strategic framework for malaria prevention and control during pregnancy in the African region: report AFR/MAL/04/01. Brazzaville, Democratic Republic of Congo: WHO Regional Office for Africa, 2004.
11. Parise ME, Ayisi JG, Nahlen BL, et al. Efficacy of sulfadoxine- pyrimerhamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg 1998; 59:813-22.
12. Filler S, Kazembe P, Thigpen M, et al. Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi. J Infect Dis 2006; 194:286-93 (in this issue).
13. Pyrimethamine, sulfadoxine. In: Mosby's drug consult. 16th ed. St. Louis, MO: Elsevier, 2006.
14. Rogerson SJ, Mkundika P, Kanjala MK. Diagnosis of Plasmodium falciparum malaria at delivery: comparison of blood film preparation methods and of blood films with histology. J Clin Microbiol 2003; 41:1370-4.
15. Bardaji A, Sigauque B, Romagosa C, Amos S, Alonso PL, Menendez C. Clinical presentation of malaria among pregnant women from a rural area of southern Mozambique [abstract 625]. In: Program and abstracts of the 53rd annual meeting of the American Society of Tropical Medicine and Hygiene (Miami Beach, FL). Chicago: American Society of Tropical Medicine and Hygiene, 2004: 185.
16. Hamer DH, Mwanakasale V, Chalwe V, et al. Intermittent presumptive therapy of malaria with SP in HIV-seropositive Zambia women: a placebo-controlled, randomized trial [abstract 54]. In: Program and abstracts of the 54th annual meeting of the American Society of Tropical Medicine and Hygiene (Washington, DC). Chicago: American Society of Tropical Medicine and Hygiene, 2005: 19.
17. Rogerson SJ, Chaluluka E, Kanjala M, Mkundika P, Mhango CG, Molyneux ME. Intermittent sulphadoxine-pyrimethamine in pregnancy: effectiveness against malaria morbidity in Blantyre, Malawi 1997-1999. Trans R Soc Trop Med Hyg 2000; 94:549-53.
18. Holtz TH, Kachur SP, Roberts JM, et al. Use of antenatal care services and intermittent preventive treatment for malaria among pregnant women in Blantyre District, Malawi. Trop Med Int Health 2004; 9:77-82.
19. Gamble C, Ekwaru JP, ter Kuile FO. Insecticide-treated nets for the prevention of malaria in pregnancy. Cochrane Database Syst Rev 2006; 2:CD003755.
20. Brentlinger PE, Behrens CB, Micek MA. Challenges in the concurrent management of malaria and HIV in pregnancy in sub-Saharan Africa. Lancet Infect Dis 2006; 6:100-11.
21. Njagi JK, Magnussen P, Estambale B, Ouma J, Mugo B. Prevention of anaemia in pregnancy using insecticide-treated bednets and sulfadoxine-pyrimethamine in a highly malarious area of Kenya: a randomized controlled trial. Trans R Soc Trop Med Hyg 2003; 97: 277-82.
22. Curtis C, Maxwell C, Lemnge M, et al. Scaling-up coverage with insecticide-treated nets against malaria in Africa: who should pay? Lancet Infect Dis 2003; 3:304-7.
23. Grabowsky M, Farrell N, Hawley W, et al. Integrating insecticide-treated bednets into a measles vaccination campaign achieves high, rapid and equitable coverage with direct and voucher-based methods. Trop Med Int Health 2005; 10:1151-60.
24. Webster J, Lines J, Bruce J, Armstrong Schellenberg JR, Hanson K. Which delivery systems reach the poor: a review of equity of coverage of ever-treated nets, never-treated nets, and immunisation to reduce child mortality in Africa. Lancet Infect Dis 2005; 5:709-17.
25. World Health Organization (WHO). WHO expert consultation on cotrimoxazole prophylaxis in HIV infection. Geneva: WHO, 2006.
26. Thera MA, Sehdev PS, Coulibaly D, et al. Impact of trimethoprim- sulfamethoxazole prophylaxis on falciparum malaria infection and disease. J Infect Dis 2005; 192:1823-9.
27. Czeizel A. A case-control analysis of the teratogenic effects of co-trimoxazole. Reprod Toxicol 1990; 4:305-13.
28. Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 2000; 343:1608-14.
29. Siega-Riz AM, Savitz DA, Zeisel SH, Thorp JM, Herring A. Second trimester folate status and preterm birth. Am J Obstet Gynecol 2004; 191:1851-7.
30. Marti-Carvajal A, Pena-Marti G, Comunian-Carrasco G, et al. Prematurity and maternal folate deficiency: anemia during pregnancy study group results in Valencia, Venezuela. Arch Latinoam Nutr 2004; 54:45-9.
31. Juarez-Vazquez I, Bonizzoni E, Scotti A. Iron plus folate is more effective than iron alone in the treatment of iron deficiency anaemia in pregnancy: a randomised, double blind clinical trial. BJOG 2002; 109:1009-14.
32. World Health Organization (WHO). Susceptibility of Plasmodium falciparum to antimalarial drugs: report on global monitoring 1996-2004. Geneva: WHO, 2005.
33. Alker AP, Mwapasa V, Purfield A, et al. Mutations associated with sulfadoxine-pyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre, Malawi. Antimicrob Agents Chemother 2005; 49:3919-21.